A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome

被引:23
作者
Zagaria, A
Anelli, L
Albano, F
Storlazzi, CT
Liso, A
Roberti, MG
Buquicchio, C
Liso, V
Rocchi, M
Specchia, G
机构
[1] Univ Bari, Dept Hematol, I-70124 Bari, Italy
[2] Univ Bari, Dipartimento Anat Patol & Genet, Sez Genet, I-70126 Bari, Italy
[3] Univ Foggia, Dept Hematol, I-71100 Foggia, Italy
关键词
D O I
10.1016/j.cancergencyto.2003.08.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The t(9;22)(q34;q11) is evident in more than 90% of patients with chronic myelocytic leukemia (CML) and gives rise to the Philadelphia chromosome (Ph). Approximately 5%-10% of CML patients show variant translocations involving other chromosomes in addition to chromosomes 9 and 22. In some variant translocations, additional material is transferred on der(22), resulting in a masked Ph chromosome. In this paper, we report two apparently Ph-negative (Ph-) CML cases showing a t(7;9;22)(q22;q34;q11) and a t(8;9;22)(q12;q34;q11), respectively. A detailed molecular cytogenetic characterization was performed by fluorescence in situ hybridization (FISH), which disclosed the presence of the 5'BCR/3'ABL fusion gene on the der(7) and der(8) chromosomes, respectively. Derivative (22) appeared as a masked Ph chromosome in both cases. FISH analysis with appropriate BAC/PAC clones allowed us to precisely characterize the complex chromosomal rearran-ements that were not detected by conventional cytogenetic analysis. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:81 / 85
页数:5
相关论文
共 30 条
[1]  
[Anonymous], 2003, MITELMAN DATABASE CH
[2]  
Aurich J, 1998, HEMATOL CELL THER, V40, P149
[3]   C-ABL AND BCR ARE REARRANGED IN A PH1-NEGATIVE CML PATIENT [J].
BARTRAM, CR ;
KLEIHAUER, E ;
DEKLEIN, A ;
GROSVELD, G ;
TEYSSIER, JR ;
HEISTERKAMP, N ;
GROFFEN, J .
EMBO JOURNAL, 1985, 4 (03) :683-686
[4]   GAMMA-GLUTAMYL-TRANSFERASE - NUCLEOTIDE-SEQUENCE OF THE HUMAN PANCREATIC CDNA - EVIDENCE FOR A UBIQUITOUS GAMMA-GLUTAMYL-TRANSFERASE POLYPEPTIDE IN HUMAN TISSUES [J].
COURTAY, C ;
OSTER, T ;
MICHELET, F ;
VISVIKIS, A ;
DIEDERICH, M ;
WELLMAN, M ;
SIEST, G .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (12) :2527-2533
[5]  
Fischer K, 1998, RECENT RESULTS CANC, V144, P46
[6]   COMPLEX CHROMOSOMAL TRANSLOCATIONS IN THE PHILADELPHIA-CHROMOSOME LEUKEMIAS - SERIAL TRANSLOCATIONS OR A CONCERTED GENOMIC REARRANGEMENT [J].
FITZGERALD, PH ;
MORRIS, CM .
CANCER GENETICS AND CYTOGENETICS, 1991, 57 (02) :143-151
[7]   Possible prediction of myeloid and lymphoid crises in chronic myelocytic leukemia at onset by determining the methylation status of the major breakpoint cluster region [J].
Ge, XQ ;
Tanaka, K ;
Mansyur, A ;
Tazawa, H ;
Iwato, K ;
Kyo, T ;
Dohy, H ;
Kamada, N .
CANCER GENETICS AND CYTOGENETICS, 2001, 126 (02) :102-110
[8]   TRANSLOCATION OF C-ABL TO MASKED PH IN CHRONIC MYELOID-LEUKEMIA [J].
HAGEMEIJER, A ;
DEKLEIN, A ;
GODDESALZ, E ;
TURCCAREL, C ;
SMIT, EME ;
VANAGTHOVEN, AJ ;
GROSVELD, GC .
CANCER GENETICS AND CYTOGENETICS, 1985, 18 (02) :95-104
[9]   A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa [J].
Hasford, J ;
Pfirrmann, M ;
Hehlmann, R ;
Allan, NC ;
Baccarani, M ;
Kluin-Nelemans, JC ;
Alimena, G ;
Steegmann, JL ;
Ansari, H .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (11) :850-858
[10]   CYTOGENETIC PECULIARITIES IN CHRONIC MYELOGENOUS LEUKEMIA [J].
HILD, F ;
FONATSCH, C .
CANCER GENETICS AND CYTOGENETICS, 1990, 47 (02) :197-217